Kissei Pharmaceutical Co - Delisted Pink Sheet
Kissei Pharmaceutical Co is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Kissei Pharmaceutical was actively traded.
Valuation
Check how we calculate scores
Kissei Pharmaceutical Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Kissei Pharmaceutical market risk premium is the additional return an investor will receive from holding Kissei Pharmaceutical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Kissei Pharmaceutical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Kissei Pharmaceutical's alpha and beta are two of the key measurements used to evaluate Kissei Pharmaceutical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.29 | |||
| Standard Deviation | 6.66 | |||
| Variance | 44.34 | |||
| Risk Adjusted Performance | 0.0593 |
View Kissei Pharmaceutical Related Equities
| Risk & Return | Correlation |
Kissei Pharmaceutical Corporate Directors
Kissei Pharmaceutical corporate directors refer to members of a Kissei Pharmaceutical board of directors. The board of directors generally takes responsibility for the Kissei Pharmaceutical's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Kissei Pharmaceutical's board members must vote for the resolution. The Kissei Pharmaceutical board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Yasuo Takehana | Director of Research Planning in Main Research Unit, Director | Profile | |
| Yoshio Furihata | Chief Director of Development, Director | Profile | |
| Takuo Asakawa | Director of General Affairs, Director | Profile | |
| Hiroshi Kusama | Chief Director of Production, Director | Profile |
Still Interested in Kissei Pharmaceutical Co?
Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Kissei Pharmaceutical information on this page should be used as a complementary analysis to other Kissei Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Kissei Pink Sheet
If you are still planning to invest in Kissei Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kissei Pharmaceutical's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |